|
Kava (also known as kava kava or Piper methysticum) is a member of the pepper family and has traditionally been cultivated by Pacific Islanders for use as a social and ceremonial drink - either ground or chewed up and mixed with water or coconut milk. Some Aboriginal communities also use kava. (Source: Kava fact sheet - April 2005 [Australian Government Department of Health and Ageing] )
Follow the links below to find information about the therapeutic and recreational use of kava .
Reviewed May 2008
Printer friendly page
| Results 1 to 9 displayed. |
| Title: |
Kava
|
| Publisher: |
Better Health Channel
|
| Description: |
Kava is a drug that comes from the roots of the plant Piper methysticum. It is consumed as a drink or supplement. In small doses, effects include muscle relaxation and sleepiness. Long-term use leads to a range of problems including liver damage and apathy.
|
| Date: |
Jul 2008
|
| Title: |
Indigenous misuse of kava, pharmaceuticals and other drugs
|
| Publisher: |
Australian Indigenous HealthInfoNet
|
| Description: |
This web resource is a 'one-stop info-shop' for people interested in addressing the misuse of kava, pharmaceuticals and other drugs within Aboriginal and Torres Strait Islander communities. You will also find a yarning place that provides electronic services to encourage information-sharing and collaboration.
|
| Date: |
Jun 2008
|
| Title: |
Media release. Kava monitoring, control and buy-back scheme
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
The Australian Government has announced a buy-back scheme for kava impounded by Customs at Australia's borders. The buy-back scheme, to be administered by the Office of Chemical Safety, follows the Government's tightening of import restrictions on kava to combat abuse and significant associated health problems in some Indigenous communities.
|
| Date: |
Jul 2007
|
| Title: |
Kava fact sheet - April 2005
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
Since 2001, the Therapeutic Goods Administration (TGA) has closely followed mounting international concerns over reports of hepatotoxicity and deaths from liver failure associated with taking some kava-containing medicines.
|
| Date: |
Apr 2005
|
| Title: |
Kava extract versus placebo for treating anxiety
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Systematic literature searches were conducted to assess the evidence for or against the effectiveness of kava extract for treating anxiety. Twenty-two potentially relevant double-blind, placebo-controlled RCTs were identified. Twelve trials met the incl...
|
| Date: |
Nov 2002
|
| Title: |
Information for sponsors: Safety of kava-containing medicines
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
The Therapeutic Goods Administration (TGA) has viewed with increasing concern international reports of liver damage (hepatotoxicity) associated with the use of kava-containing medicines. The TGA believes that, as a precaution, a voluntary recall to consumer level of all medicines containing kava on sale in Australia should commence immediately.
|
| Date: |
Aug 2002
|
| Title: |
Consumer advice on kava
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
The Therapeutic Goods Administration (TGA) would like to alert you to emerging concern about medicines containing kava (also known as kava kava or Piper methysticum).
|
| Date: |
Feb 2002
|
| Title: |
Kava practitioner alert
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
The Therapeutic Goods Administration (TGA) alerts health professionals to emerging concern about medicines containing kava (also known as kava kava or Piper methysticum).
|
| Date: |
Feb 2002
|
| Results 1 to 9 displayed. |
|
